XLO - Balance Sheet - Xilio Therapeutics, Inc.

Current Liabilities	27.3 M
Accounts Payable	2.57 M
Short-Term Debt	1.19 M
Other Current Liabilities	23.5 M
Non-Current Liabilities	26.2 M
Long-Term Debt	0
Other Non-Current Liabilities	26.2 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	55.3	44.7	120.4	198.1	19.2	48.8
Short Term Investments	0	0	0	0	0	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	4.9	3.4	8.2	8.9	1.4	2.3
Total Current Assets	60.2	48.1	124.5	202.5	20.6	51.1
PP&E	9.1	11.2	12.8	13.6	13.7	9.9
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	1.6	1.6	1.6	0.2
Other Long Term Assets	1.8	1.6	0.3	1.9	0.5	1.6
Other Assets	0	0	0	0	0	0
Total Assets	71.1	60.9	139.2	218.1	36.3	62.7
LIABILITIES
Accounts Payable	2.6	1.1	3.1	3.1	5.4	2.5
Short Term Debt	1.2	3.3	7.6	0.8	2.9	0
Other Current Liabilities	10.0	11.6	10.4	8.8	13.8	2.7
Total Current Liabilities	27.3	16.0	21.1	12.8	22.2	5.2
Long Term Debt	0	8.1	12.4	19.7	18.3	18.6
Deferred Tax Income	0	0	0	3.5	0	0
Other Liabilities	0	1	45 K	0.1	79.1	68.4
Total Liabilities	53.5	24.1	33.5	32.6	119.6	92.2
EQUITY
Common Stock	5 K	3 K	3 K	3 K	1 K	0
Retained Earnings	(383.8)	(325.5)	(249.1)	(160.9)	(85.1)	(29.9)
Other Accumulative Comprehensive Income/Loss	0	0	0	(218.1)	(78.0)	0
Total Equity	17.6	36.8	105.6	185.4	(83.3)	(29.5)
Total Liabilities and Equity	71.1	60.9	139.2	218.1	36.3	62.7
SHARES OUTSTANDING
Common Shares Outstanding	53.5	27.5	27.4	27.4	27.5	27 468.9

Free